Auris Medical's phase III trial of Keylizen does not meet its two coprimary efficacy endpoints Aug. 19, 2016
Boehringer Ingelheim and Kyoto University to investigate new drugs for sensorineural hearing loss April 5, 2016
3D-printed biomimetic tympanic membrane shows similar acoustic properties to human eardrum Jan. 26, 2016
RSS